Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype
- PMID: 12379748
- DOI: 10.1097/01.MP.0000028573.34289.04
Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype
Abstract
Both beta-catenin and E-cadherin are epithelial cell adhesion molecules. In addition, beta-catenin is an important element of the Wnt signal transduction pathway, which has been implicated in embryogenesis and carcinogenesis, including the development of endometrial and ovarian endometrioid carcinomas. We hypothesized that the expression pattern of these two adhesion molecules may depend upon the histological subtype of endometrial carcinomas. Therefore, we compared the immunohistochemical expression of beta-catenin and E-cadherin in a set of uterine adenocarcinomas matched for high histologic grade, that is, poorly differentiated (International Federation of Gynecology and Obstetrics [FIGO] Grade III) uterine endometrioid carcinomas and uterine serous carcinomas. Seventeen FIGO Grade III endometrioid adenocarcinomas and 17 serous carcinomas were evaluated histologically and immunohistochemically with commercially available monoclonal antibodies against beta-catenin and E-cadherin. Nuclear expression of beta-catenin was observed in 8 of 17 (47%) endometrioid adenocarcinomas but in none of the serous carcinomas (P = .003). Moderate or strong E-cadherin expression was identified in 7 of 17 (41%) serous carcinomas as opposed to in only 1 of 17 (6%) endometrioid adenocarcinomas (P = .02). The majority of endometrioid adenocarcinomas showed strong beta-catenin expression coupled with weak E-cadherin expression; serous carcinomas did not exhibit a comparable trend. Our results indicate that the expression of beta-catenin and E-cadherin in high-grade endometrial cancers is strongly associated with histological subtype. These data provide further support for the distinct molecular profiles of endometrioid adenocarcinoma and serous carcinoma. Notably, differences in cell adhesion molecule expression could account for variations in patterns of tumor dissemination. The immunohistochemical staining pattern may also be useful for diagnostic purposes.
Similar articles
-
Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression.Anticancer Res. 2004 Nov-Dec;24(6):3843-50. Anticancer Res. 2004. PMID: 15736420
-
Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.Hum Pathol. 2006 Aug;37(8):1042-9. doi: 10.1016/j.humpath.2006.03.003. Epub 2006 Jun 2. Hum Pathol. 2006. PMID: 16867867
-
MMP-2, TIMP-1, E-cadherin, and beta-catenin expression in endometrial serous carcinoma compared with low-grade endometrial endometrioid carcinoma and proliferative endometrium.Acta Obstet Gynecol Scand. 2008;87(8):868-74. doi: 10.1080/00016340802253775. Acta Obstet Gynecol Scand. 2008. PMID: 18607832
-
A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.Verh Dtsch Ges Pathol. 1997;81:228-32. Verh Dtsch Ges Pathol. 1997. PMID: 9474874 Review.
-
Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.Mod Pathol. 2000 Apr;13(4):379-88. doi: 10.1038/modpathol.3880062. Mod Pathol. 2000. PMID: 10786803 Review.
Cited by
-
Role of epithelial to mesenchymal transition proteins in gynecological cancers: pathological and therapeutic perspectives.Tumour Biol. 2014 Oct;35(10):9523-30. doi: 10.1007/s13277-014-2537-1. Epub 2014 Aug 29. Tumour Biol. 2014. PMID: 25168372 Review.
-
Integrative Analysis of Differently Expressed Genes Reveals a 17-Gene Prognosis Signature for Endometrial Carcinoma.Biomed Res Int. 2021 Jul 14;2021:4804694. doi: 10.1155/2021/4804694. eCollection 2021. Biomed Res Int. 2021. PMID: 34337010 Free PMC article.
-
Application of Immunohistochemistry and Molecular Diagnostics to Clinically Relevant Problems in Endometrial Cancer Bojana Djordjevic, Shannon Westin, Russell R. Broaddus.Surg Pathol Clin. 2012 Dec 1;5(4):859-878. doi: 10.1016/j.path.2012.08.004. Surg Pathol Clin. 2012. PMID: 23687522 Free PMC article.
-
Personalized therapy in endometrial cancer: challenges and opportunities.Cancer Biol Ther. 2012 Jan 1;13(1):1-13. doi: 10.4161/cbt.13.1.18438. Epub 2012 Jan 1. Cancer Biol Ther. 2012. PMID: 22198566 Free PMC article. Review.
-
Molecular determinants of invasion in endometrial cancer.Clin Transl Oncol. 2007 May;9(5):272-7. doi: 10.1007/s12094-007-0054-z. Clin Transl Oncol. 2007. PMID: 17525037 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous